• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs World's First Single-Use Duodenoscope

    Dr. Stephen Hahn Confirmed as New FDA Leader

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    MedStar Health and Cleveland Clinic Innovations Awarded Grant

    3M to Sell Drug Delivery Business for $650M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    S-Y-M Products Company

    NN Life Sciences/Paragon Medical

    Nelson Laboratories LLC

    RJG Inc.

    Eurofins Medical Device Testing
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    DELMIAWORKS (IQMS)

    MicroLumen Inc.

    S-Y-M Products Company

    Command Medical Products Inc.

    Lyons
    Editorial

    Will Regulatory Transitions Cause Some to Change Course?

    Will Regulatory Transitions Cause Some to Change Course?
    Related CONTENT
    • Droning on About Medtech
    • Mike on Medtech: Human Factors
    • The Next Frontier of Medicine May Very Well Be in Your Pocket
    • Mike on Medtech: Pre-Sub with the FDA
    • Too Big to Fail
    Sean Fenske, Editor-in-Chief04.03.18
    Now, perhaps more than ever before, there are significant changes occurring to the worldwide regulatory landscape, all within a relatively small window. This includes FDA, the EU’s MDR, Asia (see the article in this issue on India’s new rules), and MDSAP. The transformations have the industry scrambling to ensure compliance across the board within their respective markets. With this in mind, I reached out to several regulatory thought leaders to hear what they had to say about the changing environment and what it would mean for the medical device industry.

    “Brexit, the new MDR regulation, MDSAP, and increased regulatory requirements in countries such as Brazil are increasing international regulatory requirements. Meanwhile, the U.S. FDA is focused on lowering the regulatory burden for regulated industry, however, with only marginal success,” explained James A. Dunning, principal at QPC Services. “The result of these changes is that the U.S. and global regulatory requirements will be more aligned. U.S. medical device companies will be more likely to launch new products in the U.S. first, and then launch globally.”

    “The FDA’s regulatory process remains the gold standard for safety and efficacy of medical technology innovation, and it is critical that we maintain this global leadership position,” stated Mark Leahey, president and CEO of the Medical Device Manufacturers Association (MDMA). “While there have been challenges over the years, there continues to be significant improvements in the FDA’s regulatory pathways. MDMA worked closely with the FDA and various stakeholders to build on these improvements on the recent MDUFA reauthorization, and Congress strengthened the innovation ecosystem in the ‘Cures Act.’”

    “Global regulatory landscapes are undergoing a major transformation. Gone are the days of first to market in the EU, with many companies looking to introduce devices in the U.S. first. The U.S. FDA is working to streamline the regulatory framework for introducing innovative medical devices as well as making it more efficient and predictable,” said Daniel R. Matlis, president at Axendia Inc. “On the other hand, new EU rules on medical devices will impose tighter controls on devices. Controls will also be tightened on clinical trials as well as on the bodies that can approve the marketing of medical devices. In addition, once devices are available for use on the market, manufacturers will be obliged to collect data about their performance to support tighter post-market surveillance.”

    Sandra K. Rodriguez, market analyst at Axendia Inc., added, “Companies are still evaluating the impact of EU MDR compliance on their products and processes, reassessing their product portfolios to determine if it makes sense to invest in the necessary resources, time, and technology to support compliance. The challenge we’ve seen is the still unknown cost of EU MDR compliance as companies struggle to justify the investment in legacy products. Another interesting trend was the concern over master data management as a result of silo’d and distributed systems across functional areas. Total product lifecycle management can only happen with the right infrastructure to support master data management.”

    “The MDR will significantly change the European market when it takes effect in 2020. For example, claiming equivalence will be much more difficult to prove. As a result, many device manufacturers may not choose to release their products in Europe first,” predicted Alex Butler, manager of medical device solutions at MasterControl. “I see the MDSAP program as a win-win for medtech firms and regulatory bodies. The harmonized program will ease compliance burdens of companies and free-up resources for regulators.”

    “The medical device and IVD regulations are now officially in place in Europe, making it harder for medical devices to get to—and stay in—the EU market. Prior to the mid-2017 changes, Europe was the go-to market to launch a medical device product while waiting on FDA and Health Canada approval. Now, many are beginning to rethink their go-to-market strategy,” explained Jon Speer, founder and VP of QA/RA at Greenlight Guru. “Going forward, manufacturers will need to place greater emphasis on risk management, clinical data, and evaluations to remain in compliance.”

    “We have not seen and don’t anticipate a shift in market strategies associated with the many changes occurring in the regulatory landscape until the Notified Bodies (NB) for the MDR have been designated and the level of scrutiny experienced,” said Maria Fagan, co-founder and president of Regulatory and Quality Solutions (R&Q). “The first round of NB designations is expected in Q1 2019. If the NB interpretation rigor is high, as we anticipate based on our industry perspective, companies will begin shifting their market strategies to allow for more time to get into the EU and perhaps enter other countries first, depending on their EU medical market size and the risk to their business revenue.”
    Related Searches
    • market
    • innovation
    • data
    • mdsap
    Suggested For You
    A Vision of Healthcare’s Future…in 3D A Vision of Healthcare’s Future…in 3D
    Mike on Medtech: Quality vs. Regulatory Mike on Medtech: Quality vs. Regulatory
    Investing Time in San Francisco Investing Time in San Francisco
    Mike on Medtech: The Mike on Medtech: The 'New' Alternative 510k
    Mike on Medtech: Regulatory Approval Pathway for Biomaterials Mike on Medtech: Regulatory Approval Pathway for Biomaterials
    Operating Devices with an Off-the-Shelf Solution Operating Devices with an Off-the-Shelf Solution
    5 Medtech Trends Shaping 2017: Disruption from Outsiders 5 Medtech Trends Shaping 2017: Disruption from Outsiders
    5 Medtech Trends Shaping 2017: Trump’s Impact 5 Medtech Trends Shaping 2017: Trump’s Impact
    5 Medtech Trends Shaping 2017: The Pharma/Medtech Convergence 5 Medtech Trends Shaping 2017: The Pharma/Medtech Convergence
    Your Device Is Only as Good as Its Product Dossier: 4 Management Tips Your Device Is Only as Good as Its Product Dossier: 4 Management Tips
    Too Big to Fail Too Big to Fail
    Mike on Medtech: Pre-Sub with the FDA Mike on Medtech: Pre-Sub with the FDA
    The Next Frontier of Medicine May Very Well Be in Your Pocket The Next Frontier of Medicine May Very Well Be in Your Pocket
    Mike on Medtech: Human Factors Mike on Medtech: Human Factors
    Droning on About Medtech Droning on About Medtech

    Related Editorial

    • Tidying Up: What

      Tidying Up: What's on Medtech's To-Do List?

      Both small and large firms take time to map out their strategy for the next year; industry may want to take the same approach to address pending concerns.
      Sean Fenske, Editor-in-Chief 11.04.19

    • Diversity, Inclusion, and Innovation at The MedTech Conference

      Diversity, Inclusion, and Innovation at The MedTech Conference

      This year’s MedTech Conference celebrated several themes, including a need for diversity, the evolution of innovation, and the changing regulatory environment.
      Sean Fenske, Editor-in-Chief 10.08.19

    • Diagnostics | Digital Health | Patient Monitoring
      The Legacy of Apple Health

      The Legacy of Apple Health

      Does Apple Health present the opportunity to be the company's greatest contribution to mankind or will it falter due to a lack of direction?
      Sean Fenske, Editor-in-Chief 09.06.19


    • Catching Its Breath: Observations from the 2019 Top Companies Reports

      Catching Its Breath: Observations from the 2019 Top Companies Reports

      The medical device industry has become quite accustomed to megamergers that see two of its largest players join forces to generate a more robust product portfolio. In recent years, we’ve seen the marriage of Medtronic and Covidien, BD and Bard,…
      Sean Fenske, Editor-in-Chief 07.30.19

    • Thoughts on the NY Times Editorial Board Statement

      Thoughts on the NY Times Editorial Board Statement

      To say the image of the medical device industry is unfavorable with the general public recently is an enormous understatement. Regrettably, in 20 years of covering this industry, I can’t recall a time the view of medtech has been as low as it&r…
      Sean Fenske, Editor-in-Chief 06.13.19

    • Contract Manufacturing
      The Evolution of Outsourcing

      The Evolution of Outsourcing

      According to Grand View Research, the global medical device outsourcing market was valued at $94.2 billion last year and is anticipated to grow at a very healthy 10.5 percent CAGR through 2026. That analysis includes contract manufacturing, regulator…
      Sean Fenske, Editor-in-Chief 05.01.19


    • Diagnostics
      Fake It Until You Make It: Comments on the Theranos Documentary

      Fake It Until You Make It: Comments on the Theranos Documentary

      Anyone who has already seen the documentary running on HBO, “The Inventor: Out for Blood in Silicon Valley,” will likely recognize the phrase I used as the headline for this issue’s Letter. While it’s not new or unique to that…
      Sean Fenske, Editor-in-Chief 04.03.19

    • Going Beyond the Conversation in Addressing the Skills Gap

      Going Beyond the Conversation in Addressing the Skills Gap

      Unless you’ve gone willfully about without reading any news, watching television, surfing the internet, or speaking with colleagues, you’ve undoubtedly heard about the growing skills gap (or labor shortage or whatever other term you want…
      Sean Fenske, Editor-in-Chief 03.07.19

    • Continuing on the 510(k) Pathway or Finding a Different Route?

      Continuing on the 510(k) Pathway or Finding a Different Route?

      In my last Editor’s Letter, one of my “holiday wish list” items for 2019 was an improved industry image. To the general public, that includes the FDA and its oversight and regulations tied to medical devices. As such, efforts to enh…
      Sean Fenske, Editor-in-Chief 01.30.19


    • The Sun Will Shine Again: Preparing for Change

      The Sun Will Shine Again: Preparing for Change

      Change is not typically something many have an easy time with. I know for me personally, it can present a challenge. The changing of clocks after Halloween, for example, can be a bit depressing as the days seem to shorten very quickly. It’s alw…
      Howard Revitch, Group Publisher 01.03.19

    • My Holiday Wish List (for Industry)

      My Holiday Wish List (for Industry)

      It’s unbelievable to realize I’m once again writing an end-of-the-year Editor’s Letter; 2018 seemed to pass by in a blur. All good things…well, you know. The timing does, however, offer the opportunity to consider my 2018…
      Sean Fenske, Editor-in-Chief 11.26.18

    • 3D/Additive Manufacturing | Surgical
      Regulating the Practice of Medicine

      Regulating the Practice of Medicine

      In the latest issue of MPO’s sister publication, Orthopedic Design & Technology (ODT), my Editor’s Letter posed a question regarding regulatory approval of implants. Specifically, I wondered if all implanted devices should be required…
      Sean Fenske, Editor-in-Chief 10.16.18

    • Damning Documentary or Tugging at Heartstrings? A Look at ‘The Bleeding Edge’

      Damning Documentary or Tugging at Heartstrings? A Look at ‘The Bleeding Edge’

      Recently, I watched the controversial medical device industry documentary, “The Bleeding Edge,” featured on Netflix. For those who have not had the opportunity to view it, I would certainly encourage you to do so. I would also encourage y…
      Sean Fenske, Editor-in-Chief 09.07.18

    • Strategic Refocusing

      Strategic Refocusing

      What was I just saying in my Letter last issue? The more things change…? Well, it holds true going forward in this issue too—our annual Top Companies report. This expansive offering provides an in-depth look at the happenings within the…
      Sean Fenske, Editor-in-Chief 07.27.18

    • The More Things Change…

      The More Things Change…

      For many, an anniversary presents an obvious time to reflect on the past—what’s been accomplished, where you’ve been, memories you’ve had. For me, MPO’s 15th anniversary is an unusual situation. While I was writing about…
      Sean Fenske, Editor-in-Chief 06.04.18


    Breaking News
    • FDA OKs World's First Single-Use Duodenoscope
    • Dr. Stephen Hahn Confirmed as New FDA Leader
    • FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    • MedStar Health and Cleveland Clinic Innovations Awarded Grant
    • 3M to Sell Drug Delivery Business for $650M
    View Breaking News >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.